Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Alkem Laboratories Business Update

Alkem Laboratories Limited's manufacturing facility in Amaliya, Daman, underwent a US FDA inspection from April 20 to May 1, 2026. The company received Form 483 with seven observations and intends to address them within the stipulated timeframe. This is a routine regulatory update regarding facility compliance.

Source

NSE filing, NSE: ALKEM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Alkem Laboratories Ltd: key numbers

Share price
₹5,113.50
Market cap
₹61,140 Cr
Revenue (annual)
₹14,712 Cr
Net profit (annual)
₹2,302 Cr
P/E (TTM)
28.3×Sector 48.7×
Promoter holding
49.70%+0.00% QoQ
FII holding
10.32%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Alkem Laboratories Ltd

All →

Other business update announcements

All →